2025 annual financial data
ORIC Pharmaceuticals 2025 Net income growth
Direct answer
Net income growth was -1.27%.
Operating income was -143,004,000 USD and net income was -129,468,000 USD.
Operating cash flow was -113,367,000 USD.
Get free ORIC Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -143,004,000 USD
- Net income
- -129,468,000 USD
- Operating cash flow
- -113,367,000 USD